Medline Debuts on Nasdaq After Largest IPO of 2025
Shares of the American medical supply giant Medline jumped in its debut on the Nasdaq on Wednesday after the largest…
Biotechnology
Pfizer reaches agreement with YaoPharma for an anti-obesity pill
Pfizer CEO Albert Bourla speaks during a press conference with European Commission President Ursula von der Leyen after a visit…
Zealand Pharma unveils 2030 plan as weight loss competition heats up
Celsopupo | Stock | fake images Zealand Pharma outlined an ambitious five-year strategy for its anti-obesity portfolio on Thursday, highlighting…
Eli Lilly's weight-loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Eli Lilly to build $6 billion manufacturing plant in Alabama
Eli Lilly CEO David A. Ricks speaks at a news conference at Generation Park in Houston, Monday, Sept. 23, 2025.…
RFK Jr. Vaccine Panel Postpones Vote on Infant Hepatitis B Vaccine
Health and Human Services Secretary Robert F. Kennedy Jr.'s hand-picked vaccine committee on Thursday postponed crucial votes on hepatitis B…
Eli Lilly cuts cash prices on vials of weight-loss drug Zepbound
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Eli Lilly reaches $1 trillion market value, first for a healthcare company
A sign with the company's logo sits outside Eli Lilly's headquarters in Indianapolis, Indiana, on March 17, 2024. Scott Olson…
Novo Nordisk reduces Wegovy and Ozempic spot prices
Boxes of Ozempic and Wegovy manufactured by Novo Nordisk in a London pharmacy on March 8, 2024. Hollie Adams |…
Omada Health will begin prescribing GLP-1 and other obesity medications
The Omada Health logo is displayed on the screen of a smartphone. soup images | Light rocket | fake images…